Heart, Vascular & Thoracic
VITALS
Volumes and outcomes from a sampling of centers in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute
For more data like this, visit clevelandclinic.org/hvtioutcomes
and clevelandclinic.org/e15
Number of patient referrals for advanced heart failure in 2021
334
Number of left ventricular assist device (LVAD) implantations in 2021
79
Number of heart transplants in 2021, including 16 multiorgan transplants of the heart plus kidney (n = 14), lung (n = 1) or liver (n = 1)
60
OVERALL VOLUME
HEART FAILURE AND RECOVERY
Best estimate of Cleveland Clinic’s risk of 1-year graft failure vs. the national average
43% lower
3-year survival, vs. national average of 85.5%
88.1%
Estimated probability of surviving with a functioning graft at 1 year, vs. 91.2% national benchmark (unadjusted for patient and donor characteristics)
96.4%
HEART TRANSPLANT
Best estimate of Cleveland Clinic’s risk of 3-year graft failure vs. the national average
16% lower
(Source: Scientific Registry of Transplant Recipients program report of 1/6/22)
(Source: Society of Thoracic Surgeons [STS] Intermacs Quarterly Quality Assurance Report, 2021 Q4 [7/1/20-12/31/21])
1-year post-implant survival among continuous-flow LVAD recipients for destination therapy, vs. 82.2% STS Intermacs survival
83.7%
1-year post-implant survival among continuous-flow LVAD recipients as a bridge to transplant, vs. 87.8% STS Intermacs survival
96.6%
1-year post-implant survival among all LVAD recipients, vs. 83.2% STS Intermacs survival
86.8%
LVAD IMPLANTATION
(Cappato et al., Circ Arrhythm Electrophysiol. 2010)
Major complication rate, vs. benchmark of 4.5%
1.61%
AF ablations, 2017-2021
5,849
ATRIAL FIBRILLATION (AF) ABLATION
(Kusumoto et al., Heart Rhythm. 2017)
In-hospital mortality, vs. benchmark of 1.2%
0.35%
Clinical success rate for lead extractions
96.4%
Lead extraction procedures, 2017-2021
861
LEAD EXTRACTION
EP lab procedure volume, 2021
6,554
EP lab procedure volume, 2017-2021
30,143
OVERALL VOLUME
ELECTROPHYSIOLOGY (EP)
(Cronin et al., Heart Rhythm. 2020)
Major complication rate, vs. benchmark of 10%
3.6%
Ventricular arrhythmia ablations, 2017-2021
1,288
VENTRICULAR ARRHYTHMIA ABLATION
(Boersma et al., Eur Heart J. 2016)
Major complication rate within 7 days of Watchman implant, vs. benchmark of 2.7%-8.7% in published Watchman trials
2.2%
Watchman™ devices placed for LAAO procedures (inclusive of EP and interventional cases), 2017-2021
779
LEFT ATRIAL APPENDAGE OCCLUSION (LAAO)
